Replies to post #50767 on PharmaCyte Biotech Inc (PMCB)

[rudygerner]

I've maintained that all along. Imo, PharmaCyte will either get bought or partnered. The Cell-in-a-Box® technology, coupled with the patented Melligen cells, is capable of basically curing both T1 & T2 diabetes, no insulin injections or devices needed; this technology is capable of making cancerous, inoperable tumors operable by reducing their size; this technology is capable of reducing malignant ascites, a buildup of cancerous fluid in the space surrounding the organs in the abdomen. Still think big pharma isn't watching PharmaCyte? Think again.